127 related articles for article (PubMed ID: 35660675)
1. A Patient with Myxoid/Round Cell Liposarcoma (MRCL) Involving the Well-known Translocation t(12;22): A Case Report with the Cytogenomic Landscape of this Rearrangement.
Tirado CA; Su W; Chia V; Zaki M; Tang R; Eastwood K; Guardiola MT; Rao A
J Assoc Genet Technol; 2022; 48(2):68-75. PubMed ID: 35660675
[TBL] [Abstract][Full Text] [Related]
2. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
3. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Bode-Lesniewska B; Frigerio S; Exner U; Abdou MT; Moch H; Zimmermann DR
Genes Chromosomes Cancer; 2007 Nov; 46(11):961-71. PubMed ID: 17647282
[TBL] [Abstract][Full Text] [Related]
4. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
5. A cryptic EWSR1::DDIT3 fusion in myxoid liposarcoma: Potential pitfalls with FISH and cytogenetics.
Ibstedt S; de Mattos CBR; Köster J; Mertens F
Genes Chromosomes Cancer; 2023 Mar; 62(3):167-170. PubMed ID: 36379683
[TBL] [Abstract][Full Text] [Related]
6. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
[TBL] [Abstract][Full Text] [Related]
7. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.
Willmore-Payne C; Holden J; Turner KC; Proia A; Layfield LJ
Arch Pathol Lab Med; 2008 Jun; 132(6):952-7. PubMed ID: 18517278
[TBL] [Abstract][Full Text] [Related]
8. Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay.
Powers MP; Wang WL; Hernandez VS; Patel KS; Lev DC; Lazar AJ; López-Terrada DH
Mod Pathol; 2010 Oct; 23(10):1307-15. PubMed ID: 20581806
[TBL] [Abstract][Full Text] [Related]
9. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
10. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis.
Knight JC; Renwick PJ; Dal Cin P; Van den Berghe H; Fletcher CD
Cancer Res; 1995 Jan; 55(1):24-7. PubMed ID: 7805034
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
Baranov E; Black MA; Fletcher CDM; Charville GW; Hornick JL
Mod Pathol; 2021 Jul; 34(7):1367-1372. PubMed ID: 33731886
[TBL] [Abstract][Full Text] [Related]
12. Myxoid liposarcoma with cartilaginous differentiation showing
Suzuki K; Yasuda T; Watanabe K; Hori T; Kanamori M; Kimura T
Oncol Lett; 2017 Dec; 14(6):6789-6794. PubMed ID: 29181103
[TBL] [Abstract][Full Text] [Related]
13. Novel Clonal t(2;4) (q23;p14) Secondary Cytogenetic Abnormality in a Primary Myxoid Liposarcoma.
Kiyani A; Heerema NA; Mayerson JL; Scharschmidt TJ; Iwenofu OH
Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):538-40. PubMed ID: 23958553
[TBL] [Abstract][Full Text] [Related]
14. A novel type of EWS-CHOP fusion gene in myxoid liposarcoma.
Matsui Y; Ueda T; Kubo T; Hasegawa T; Tomita Y; Okamoto M; Myoui A; Kakunaga S; Yasui N; Yoshikawa H
Biochem Biophys Res Commun; 2006 Sep; 348(2):437-40. PubMed ID: 16884691
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11).
Aman P; Ron D; Mandahl N; Fioretos T; Heim S; Arheden K; Willén H; Rydholm A; Mitelman F
Genes Chromosomes Cancer; 1992 Nov; 5(4):278-85. PubMed ID: 1283316
[TBL] [Abstract][Full Text] [Related]
16. DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma.
Scapa JV; Cloutier JM; Raghavan SS; Peters-Schulze G; Varma S; Charville GW
Am J Surg Pathol; 2021 Feb; 45(2):230-239. PubMed ID: 32815829
[TBL] [Abstract][Full Text] [Related]
17. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
[TBL] [Abstract][Full Text] [Related]
18. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
[TBL] [Abstract][Full Text] [Related]
19. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
de Graaff MA; Yu JS; Beird HC; Ingram DR; Nguyen T; Juehui Liu J; Bolshakov S; Szuhai K; Åman P; Torres KE; Lev D; Nielsen TO; Bovée JV; Lazar AJ; Somaiah N
Lab Invest; 2016 Aug; 96(8):885-94. PubMed ID: 27270875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
